Takeda Pharmaceutical Company Limited (TAK)
50/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $53.6B
- P/E
- 46.1
- Sector Median P/E
- 25.6
- F-Score
- 6/9
- ROIC
- 0.2%
- FCF Yield
- 7.0%
With a Tessera Quality Score of 50, TAK ranks in the top 50% of Healthcare stocks tracked. The stock's P/E of 46.1 sits 80% above the sector median of 25.6. Piotroski F-Score is 6/9; trailing ROIC is 0.2%.
Sector Peers
- Haleon plc (HLN)Mkt Cap: $43.0B · FCF: 11.9%
- Teva Pharmaceutical Industries Limited (TEVA)Mkt Cap: $38.4B · FCF: 6.8%
- Viatris Inc. (VTRS)Mkt Cap: $18.8B · FCF: 11.7%
- Intra-Cellular Therapies, Inc. (ITCI)Mkt Cap: $14.0B · FCF: -10.8%
- Elanco Animal Health Incorporated (ELAN)Mkt Cap: $12.2B · FCF: 6.4%